Bioethics Stock Performance
| BOTH Stock | USD 0.01 0.00 0.00% |
The firm shows a Beta (market volatility) of 2.27, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bioethics will likely underperform. At this point, Bioethics has a negative expected return of -1.58%. Please make sure to confirm Bioethics' variance and kurtosis , to decide if Bioethics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bioethics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
| Begin Period Cash Flow | 667.00 | |
| Free Cash Flow | -27.5 K |
Bioethics |
Bioethics Relative Risk vs. Return Landscape
If you would invest 125.00 in Bioethics on September 26, 2025 and sell it today you would lose (124.49) from holding Bioethics or give up 99.59% of portfolio value over 90 days. Bioethics is currently does not generate positive expected returns and assumes 12.5474% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Bioethics, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bioethics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioethics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Bioethics, and traders can use it to determine the average amount a Bioethics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.126
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BOTH |
Based on monthly moving average Bioethics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioethics by adding Bioethics to a well-diversified portfolio.
Bioethics Fundamentals Growth
Bioethics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bioethics, and Bioethics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioethics Pink Sheet performance.
| Return On Asset | -56.39 | |||
| Current Valuation | 647.72 K | |||
| Shares Outstanding | 1.14 M | |||
| Price To Book | 2,021 X | |||
| EBITDA | (59.14 K) | |||
| Cash And Equivalents | 554 | |||
| Total Debt | 398.53 K | |||
| Book Value Per Share | (0.58) X | |||
| Cash Flow From Operations | (27.48 K) | |||
| Earnings Per Share | (0.09) X | |||
| Total Asset | 734 | |||
About Bioethics Performance
By evaluating Bioethics' fundamental ratios, stakeholders can gain valuable insights into Bioethics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bioethics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bioethics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States.Things to note about Bioethics performance evaluation
Checking the ongoing alerts about Bioethics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bioethics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioethics generated a negative expected return over the last 90 days | |
| Bioethics has high historical volatility and very poor performance | |
| Bioethics has some characteristics of a very speculative penny stock | |
| Bioethics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (107.18 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations. | |
| Roughly 89.0% of the company shares are held by company insiders |
- Analyzing Bioethics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioethics' stock is overvalued or undervalued compared to its peers.
- Examining Bioethics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioethics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioethics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioethics' pink sheet. These opinions can provide insight into Bioethics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bioethics Pink Sheet analysis
When running Bioethics' price analysis, check to measure Bioethics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioethics is operating at the current time. Most of Bioethics' value examination focuses on studying past and present price action to predict the probability of Bioethics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioethics' price. Additionally, you may evaluate how the addition of Bioethics to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |